400-998-5282
专注多肽 服务科研
一种钙调蛋白 (CaM) 激动剂 (Kd 为 88 µM),与 CaM EF-hand/Ca2+ 结合位点结合。CALP1 通过抑制钙通道 (calcium channel) 的开放来阻止钙的流入和凋亡
编号:191002
CAS号:145224-99-3
单字母:H2N-VAITVLVK-OH
参考文献(References): | J.Dillon et al., Proc. Natl. Acad. Sci. USA, 88, 9726 (1991) M.K.Manion et al., FASEB J., 14, 1297 (2000) R.Houtman et al., J. Immunol., 166, 861 (2001) R.Ten Broeke et al., Eur. J. Pharmacol., 476, 151 (2003) |
CALP1 是一种钙调蛋白 (CaM) 激动剂 (Kd 为 88 µM),与 CaM EF-hand/Ca2+ 结合位点结合。CALP1 通过抑制钙通道 (calcium channel) 的开放来阻止钙的流入和凋亡 (IC50 为 44.78 µM)。CALP1 阻止谷氨酸受体 ( glutamate receptor channels) 通道,并阻止存储操作的非选择性阳离子通道。CALP1 激活 CaM 依赖性磷酸二酯酶 (phosphodiesterase) 活性。
CALP1 is a calmodulin (CaM) agonist (Kd of 88 µM) with binding to the CaM EF-hand/Ca2+-binding site. CALP1 blocks calcium influx and apoptosis (IC50 of 44.78 µM) through inhibition of calcium channel opening. CALP1 blocks glutamate receptor channels and blocks a store-operated nonselective cation channel. CALP1 activates CaM-dependent phosphodiesterase activity.
肽CALP-1的作用类似于Ca2+,与钙调蛋白依赖性蛋白(如钙调蛋白结合蛋白超家族、磷酸二酯酶)相互作用。
The peptide CALP-1 acts like Ca2+, interacts with the calmodulin-dependent proteins, like roponin superfamily, phosphodiesterase.
R Houtman, et al. Attenuation of very late antigen-5-mediated adhesion of bone marrow-derived mast cells to fibronectin by peptides with inverted hydropathy to EF-hands. J Immunol. 2001 Jan 15;166(2):861-7. : https://pubmed.ncbi.nlm.nih.gov/11145661
R Ten Broeke, et al. Calcium sensors as new therapeutic targets for airway hyperresponsiveness and asthma. FASEB J. 2001 Aug;15(10):1831-3. : https://pubmed.ncbi.nlm.nih.gov/11481245
M K Manion, et al. A new type of Ca(2+) channel blocker that targets Ca(2+) sensors and prevents Ca(2+)-mediated apoptosis. FASEB J. 2000 Jul;14(10):1297-306. : https://pubmed.ncbi.nlm.nih.gov/10877822
M Villain, et al. De novo design of peptides targeted to the EF hands of calmodulin. J Biol Chem. 2000 Jan 28;275(4):2676-85. : https://pubmed.ncbi.nlm.nih.gov/10644729
多肽H2N-Val-Ala-Ile-Thr-Val-Leu-Val-Lys-COOH的合成步骤:
1、合成CTC树脂:称取1.28g CTC Resin(如初始取代度约为0.79mmol/g)和1.21mmol Fmoc-Lys(Boc)-OH于反应器中,加入适量DCM溶解氨基酸(需要注意,此时CTC树脂体积会增大好几倍,避免DCM溶液过少),再加入3.03mmol DIPEA(Mw:129.1,d:0.740g/ml),反应2-3小时后,可不抽滤溶液,直接加入1ml的HPLC级甲醇,封端半小时。依次用DMF洗涤2次,甲醇洗涤1次,DCM洗涤一次,甲醇洗涤一次,DCM洗涤一次,DMF洗涤2次(这里使用甲醇和DCM交替洗涤,是为了更好地去除其他溶质,有利于后续反应)。得到 Fmoc-Lys(Boc)-CTC Resin。结构图如下:
2、脱Fmoc:加3倍树脂体积的20%Pip/DMF溶液,鼓氮气30分钟,然后2倍树脂体积的DMF 洗涤5次。得到 H2N-Lys(Boc)-CTC Resin 。(此步骤脱除Fmoc基团,茚三酮检测为蓝色,Pip为哌啶)。结构图如下:
3、缩合:取3.03mmol Fmoc-Val-OH 氨基酸,加入到上述树脂里,加适当DMF溶解氨基酸,再依次加入6.07mmol DIPEA,2.88mmol HBTU。反应30分钟后,取小样洗涤,茚三酮检测为无色。用2倍树脂体积的DMF 洗涤3次树脂。(洗涤树脂,去掉残留溶剂,为下一步反应做准备)。得到Fmoc-Val-Lys(Boc)-CTC Resin。氨基酸:DIPEA:HBTU:树脂=3:6:2.85:1(摩尔比)。结构图如下:
4、依次循环步骤二、步骤三,依次得到
H2N-Val-Lys(Boc)-CTC Resin
Fmoc-Leu-Val-Lys(Boc)-CTC Resin
H2N-Leu-Val-Lys(Boc)-CTC Resin
Fmoc-Val-Leu-Val-Lys(Boc)-CTC Resin
H2N-Val-Leu-Val-Lys(Boc)-CTC Resin
Fmoc-Thr(tBu)-Val-Leu-Val-Lys(Boc)-CTC Resin
H2N-Thr(tBu)-Val-Leu-Val-Lys(Boc)-CTC Resin
Fmoc-Ile-Thr(tBu)-Val-Leu-Val-Lys(Boc)-CTC Resin
H2N-Ile-Thr(tBu)-Val-Leu-Val-Lys(Boc)-CTC Resin
Fmoc-Ala-Ile-Thr(tBu)-Val-Leu-Val-Lys(Boc)-CTC Resin
H2N-Ala-Ile-Thr(tBu)-Val-Leu-Val-Lys(Boc)-CTC Resin
Fmoc-Val-Ala-Ile-Thr(tBu)-Val-Leu-Val-Lys(Boc)-CTC Resin
以上中间结构,均可在专肽生物多肽计算器-多肽结构计算器中,一键画出。
最后再经过步骤二得到 H2N-Val-Ala-Ile-Thr(tBu)-Val-Leu-Val-Lys(Boc)-CTC Resin,结构如下:
5、切割:6倍树脂体积的切割液(或每1g树脂加8ml左右的切割液),摇床摇晃 2小时,过滤掉树脂,用冰无水乙醚沉淀滤液,并用冰无水乙醚洗涤沉淀物3次,最后将沉淀物放真空干燥釜中,常温干燥24小试,得到粗品H2N-Val-Ala-Ile-Thr-Val-Leu-Val-Lys-COOH。结构图见产品结构图。
切割液选择:1)TFA:H2O=95%:5%、TFA:H2O=97.5%:2.5%
2)TFA:H2O:TIS=95%:2.5%:2.5%
3)三氟乙酸:茴香硫醚:1,2-乙二硫醇:苯酚:水=87.5%:5%:2.5%:2.5%:2.5%
(前两种适合没有容易氧化的氨基酸,例如Trp、Cys、Met。第三种适合几乎所有的序列。)
6、纯化冻干:使用液相色谱纯化,收集目标峰液体,进行冻干,获得蓬松的粉末状固体多肽。不过这时要取小样复测下纯度 是否目标纯度。
7、最后总结:
杭州专肽生物技术有限公司(ALLPEPTIDE https://www.allpeptide.com)主营定制多肽合成业务,提供各类长肽,短肽,环肽,提供各类修饰肽,如:荧光标记修饰(CY3、CY5、CY5.5、CY7、FAM、FITC、Rhodamine B、TAMRA等),功能基团修饰肽(叠氮、炔基、DBCO、DOTA、NOTA等),同位素标记肽(N15、C13),订书肽(Stapled Peptide),脂肪酸修饰肽(Pal、Myr、Ste),磷酸化修饰肽(P-Ser、P-Thr、P-Tyr),环肽(酰胺键环肽、一对或者多对二硫键环),生物素标记肽,PEG修饰肽,甲基化修饰肽
以上所有内容,为专肽生物原创内容,请勿发布到其他网站上。